Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
John V. Brigande

John V. Brigande

Associate Professor, Oregon Hearing Research Center, OHSU

Appears in 1 story

Stories

Gene therapy restores hearing in deaf patients

New Capabilities

Pioneering fetal gene therapy for congenital deafness

Children born profoundly deaf can now hear their parents' voices. A single injection of gene therapy into the inner ear restored hearing in dozens of patients, moving genetic deafness from permanent disability to treatable condition. The effect is rapidโ€”most patients recover hearing within weeks and retain it for at least two years.

Updated May 19